Shares Magazine
785.00p-31.50 (-4.01%)05 Nov 2025, 16:01
Jump to:
4Basebio PLC Fundamentals
| Company Name | 4Basebio PLC | Last Updated | 2025-11-05 |
|---|---|---|---|
| Industry | Biotechnology | Sector | Healthcare |
| Shares in Issue | 15.485 m | Market Cap | £116.68 m |
| PE Ratio | 0.00 | Dividend per Share | 0 |
| Dividend Yield | 0 | Dividend Cover | 0 |
| EPS | -£0.94 | EPS Growth (%) | 0 |
| PEG | 0 | DPS Growth (%) | 0 |
| Debt Ratio | 0 | Debt Equity Ratio | 0 |
| Asset Equity Ratio | 1.9422 | Cash Equity Ratio | 1.3756 |
| Quick Ratio | 10.3787 | Current Ratio | 11.36 |
| Price To Book Value | 6.4020 | ROCE | 0 |
4Basebio PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
4Basebio PLC Company Financials
| Assets | 2024 | 2023 | 2022 |
|---|---|---|---|
| Tangible Assets | £4.33 m | £4.20 m | £3.63 m |
| Intangible Assets | £3.48 m | £2.67 m | £2.12 m |
| Investments | 0 | 0 | 0 |
| Total Fixed Assets | £7.84 m | £6.90 m | £5.79 m |
| Stocks | £374,000.00 | £332,000.00 | £133,000.00 |
| Debtors | £283,000.00 | £107,000.00 | £54,000.00 |
| Cash & Equivalents | £34.60 m | £3.07 m | £4.35 m |
| Other Assets | 0 | 0 | 0 |
| Total Assets | £44.73 m | £11.92 m | £11.69 m |
| Liabilities | 2024 | 2023 | 2022 |
|---|---|---|---|
| Creditors within 1 year | £3.27 m | £2.28 m | £1.52 m |
| Creditors after 1 year | £15.08 m | £10.14 m | £3.05 m |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | £18.35 m | £12.41 m | £4.57 m |
| Net assets | £26.38 m | -£492,000.00 | £7.12 m |
| Equity | 2024 | 2023 | 2022 |
|---|---|---|---|
| Called up share capital | £13.77 m | £11.13 m | £11.13 m |
| Share Premium | £37.25 m | £706,000.00 | £706,000.00 |
| Profit / Loss | -£12.65 m | -£8.35 m | -£5.93 m |
| Other Equity | £26.38 m | -£492,000.00 | £7.12 m |
| Preference & Minorities | 0 | 0 | 0 |
| Total Capital Employed | £26.38 m | -£492,000.00 | £7.12 m |
| Ratios | 2024 | 2023 | 2022 |
|---|---|---|---|
| Debt Ratio | £0.36 | 0 | £0.29 |
| Debt-to-Equity | £0.57 | 0 | £0.41 |
| Assets / Equity | 1.9422 | 1.9422 | 1.9422 |
| Cash / Equity | 1.3756 | 1.3756 | 1.3756 |
| EPS | -£0.94 | -£0.62 | -£0.42 |
| Cash Flow | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash from operating activities | -£10.74 m | -£6.18 m | -£4.70 m |
| Cashflow before financing | £33.12 m | £247,000.00 | -£3.46 m |
| Increase in Cash | £31.55 m | -£1.24 m | -£5.40 m |
| Income | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | £933,000.00 | £506,000.00 | £268,000.00 |
| Cost of sales | £303,000.00 | £166,000.00 | £29,000.00 |
| Gross Profit | £630,000.00 | £340,000.00 | £239,000.00 |
| Operating Profit | -£12.04 m | -£8.05 m | -£5.84 m |
| Pre-Tax profit | -£12.65 m | -£8.35 m | -£5.93 m |
4Basebio PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | 4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effectively and safely delivering these DNA-based products to patients. The company operates across three geographic segments: Europe, the United States, and the Rest of the World, with the majority of its revenue generated from the United States. |
| Latest Interim Date | 29 Sep 2025 |
| Latest Fiscal Year End Date | 27 May 2025 |
4Basebio PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2025-07-08 | Mr. Timothy Paul McCarthy | Non-Executive Director,Chairman |
| 2025-05-30 | Dr. Joseph M. Fernandez | Non-Executive Director |
| 2024-06-28 | Mr. Hansjorg Plaggemars | Non-Executive Director |
| 2025-09-30 | Dr. Heikki Lanckriet, PhD | Executive Director,Chief Executive Officer |
| 2024-09-21 | Mr. David John Roth | Executive Director,Chief Financial Officer and Company Secretary |
| 2025-03-03 | Dr. Amy Jo Walker | Executive Director,Chief Operating Officer |
4Basebio PLC Contact Details
| Company Name | 4basebio PLC |
|---|---|
| Address | 25 Norman Way, Over, Cambridge, CB24 5QE |
| Telephone | +44 1223967943 |
| Website | https://www.4basebio.com |
4Basebio PLC Advisors
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Ceres Power Holdings PLC | 369.71 | 18.19 |
| Metro Bank Holdings PLC | 117.60 | 7.89 |
| Bluefield Solar Income Fund Limited | 76.90 | 6.51 |
| Trainline PLC | 267.20 | 5.03 |
| Me Group International PLC | 194.40 | 4.52 |
| Lancashire Holdings Limited | 672.00 | 4.02 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Playtech PLC | 235.00 | -5.05 |
| Weir Group PLC | 2,752.87 | -4.41 |
| Tp Icap Group PLC | 251.00 | -4.20 |
| Qinetiq Group PLC | 461.00 | -3.03 |
| Watches Of Switzerland Group PLC | 390.00 | -2.21 |
| Avon Technologies PLC | 1,880.00 | -2.19 |